PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
16-Oct-2024 Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing Cytosurge AG
16-Oct-2024 Molecure (WSE: MOC) and Nasdaq-listed biotechnology company Ocean Biomedical (NASDAQ: OCEA) sign an exclusive licensing agreement for the development and commercialization of selective YKL-40 inhibitors. Molecure S.A
16-Oct-2024 Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024 Genmab
16-Oct-2024 Refeyn introduces new mass photometry products to streamline biomolecular analysis workflows Refeyn
16-Oct-2024 Labour budget can unlock UK life science opportunities ABPI
15-Oct-2024 Biotech Capital on the Rise and Outsourcing to Accelerate in 2025 - but Uneven Growth for CDMOs CPHI Milan
15-Oct-2024 Vivan Therapeutics' inks New Five-Year Lease at London biotech hub White City Place Vivan Therapeutics
15-Oct-2024 ISPE Names Eli Lilly Kinsale Limited the 2024 Facility of the Year Awards Overall Winner ISPE
15-Oct-2024 Lynred concludes biggest space contract: Meteosat Third Generation Mission led by European Space Agency Andrew Lloyd Associates
14-Oct-2024 Aqilion presents new results from the AQ312 program (oral Ahr agonist) during UEG Week in Vienna Aqilion
14-Oct-2024 Germfree acquires Arcoplast to expand turnkey facility solutions and expand market reach through superior architectural finishes Germfree
14-Oct-2024 Lundbeck to acquire Longboard Pharmaceuticals in a strategic deal, significantly enhancing its neuroscience pipeline Lundbeck
14-Oct-2024 CNX Therapeutics CEO Guy Clark Awarded “CEO of the Year” at CPHI Pharma Awards CNX Therapeutics
14-Oct-2024 HONEYWELL TECHNOLOGY TO POWER DEVPRO BIOPHARMA’S NEXT-GENERATION LOW-EMISSION RESPIRATORY INHALER Honeywell
14-Oct-2024 New first-line treatment of Advanced Bladder (Urothelial) Cancer PADCEVTM (enfortumab vedotin) authorised in combination with KEYTRUDA® (pembrolizumab) Astellas Pharma Ltd
11-Oct-2024 Endostart secures CE marking for Endorail® – extending application from colonoscopy to enteroscopy, making complex procedures more accessible Andrew Lloyd Associates
10-Oct-2024 Ciliatech selected to showcase Intercil® Uveal Spacer, novel glaucoma surgical device, at Eyecelerator Andrew Lloyd Associates
10-Oct-2024 CNX Therapeutics CEO Guy Clark Awarded “CEO of the Year” at CPHI Pharma Awards CNX Therapeutics
10-Oct-2024 Pharming Group announces start of Phase II clinical trial of leniolisib for primary immunodeficiencies (PIDs) with immune dysregulation Pharming Group
10-Oct-2024 MitoRx Therapeutics Announces Publication Showing Mitochondrial Sulfide Donor AP39 Significantly Alleviates Obesity MitoRx Therapeutics